Viking Therapeutics Inc (NASDAQ: VKTX) on Monday, soared 0.17% from the previous trading day, before settling in for the closing price of $42.25. Within the past 52 weeks, VKTX’s price has moved between $17.23 and $99.41.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -4.64%. With a float of $108.05 million, this company’s outstanding shares have now reached $111.43 million.
In an organization with 27 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 28.9%, operating margin of -30726.61%, and the pretax margin is -22741.06%.
Viking Therapeutics Inc (VKTX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Viking Therapeutics Inc is 3.04%, while institutional ownership is 73.78%. The most recent insider transaction that took place on Nov 08 ’24, was worth 137,333. In this transaction Director of this company sold 2,000 shares at a rate of $68.67, taking the stock ownership to the 47,965 shares. Before that another transaction happened on Nov 08 ’24, when Company’s Director proposed sale 2,000 for $68.67, making the entire transaction worth $137,333.
Viking Therapeutics Inc (VKTX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to -18.89% drop over the previous five years of trading.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Viking Therapeutics Inc (VKTX) is currently performing well based on its current performance indicators. A quick ratio of 36.47 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.49 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Let’s dig in a bit further. During the last 5-days, its volume was 6.8 million. That was better than the volume of 4.48 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 33.14%. Additionally, its Average True Range was 3.23.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 10.29%, which indicates a significant decrease from 30.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 94.87% in the past 14 days, which was higher than the 81.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $57.33, while its 200-day Moving Average is $61.56. However, in the short run, Viking Therapeutics Inc’s stock first resistance to watch stands at $43.07. Second resistance stands at $43.81. The third major resistance level sits at $44.96. If the price goes on to break the first support level at $41.17, it is likely to go to the next support level at $40.02. Assuming the price breaks the second support level, the third support level stands at $39.28.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
Market capitalization of the company is 4.72 billion based on 111,436K outstanding shares. Right now, sales total 0 K and income totals -85,900 K. The company made 0 K in profit during its latest quarter, and -24,940 K in sales during its previous quarter.
